[Apoptotic induction of human lung carcinoma A549 cells by DFMO through Fas/FasL pathway]

Qing Xiang1, Mu-Zhen Fan, Bo Xu

  • 1Department of Oncology and Molecular Biology, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, PR China. xiang_qing@hotmail.com

Abstract

Insights

Alpha-difluoromethylornithine (DFMO) inhibits lung carcinoma A549 cell growth and induces apoptosis via the Fas/FasL pathway. This reversion of malignant phenotype correlates with changes in carcinoma antigen and ras P21 protein expression.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Apoptosis Research

Background:

  • The Fas/FasL pathway is crucial for regulating programmed cell death (apoptosis).
  • Polyamines are essential for cell proliferation and are often dysregulated in cancer.
  • Alpha-difluoromethylornithine (DFMO) is a known inhibitor of polyamine biosynthesis.

Purpose of the Study:

  • To investigate the role of the Fas/FasL system in polyamine biosynthesis inhibition.
  • To examine how DFMO affects malignant phenotype reversion in carcinoma cells.
  • To assess the impact of DFMO on A549 lung carcinoma cells, focusing on apoptosis and specific molecular markers.

Main Methods:

  • Cell viability was assessed using MTT assays.
  • Apoptosis was quantified via flow cytometry and DNA fragmentation analysis.
  • Gene and protein expression levels were determined using RT-PCR and immunohistochemical staining, respectively.

Main Results:

  • DFMO significantly inhibited A549 cell growth and induced apoptosis, evidenced by increased G1 phase cells and DNA laddering.
  • Expression of human lung carcinoma-associated antigen and ras P21 protein was downregulated.
  • Fas mRNA and protein expression were notably upregulated following DFMO treatment.

Conclusions:

  • DFMO effectively induces apoptosis in human lung carcinoma A549 cells, mediated by the Fas/FasL pathway.
  • The observed apoptosis induction and malignant phenotype reversion may be linked to alterations in human lung carcinoma-associated antigen and ras P21 protein expression.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.